US EditionNew Research Reveals Most Effective Obesity Drug: It’s Not Ozempic or Wegovy
Summary by Sci Tech Daily
2 Articles
2 Articles
All
Left
1
Center
1
Right
New Research Reveals Most Effective Obesity Drug: It’s Not Ozempic or Wegovy
A new clinical trial has revealed that tirzepatide (Zepbound) surpasses semaglutide (Wegovy) in promoting weight loss among people with obesity. A new clinical trial has found that tirzepatide, sold under the name Zepbound, led to significantly greater weight loss in people with obesity compared to semaglutide, known as Wegovy. Both are injectable medications designed to [...]
An old drug provides new hope: A US study shows that women with diabetes taking metformin live longer.
Coverage Details
Total News Sources2
Leaning Left1Leaning Right0Center1Last UpdatedBias Distribution50% Left, 50% Center
Bias Distribution
- 50% of the sources lean Left, 50% of the sources are Center
50% Center
L 50%
C 50%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
